Association between a Single Nucleotide Polymorphism in the 3-UTR of ARHGEF18 and the Risk of Nonidiopathic Pulmonary Arterial Hypertension in Chinese Population

Table 1

Demographic and clinical characteristics of study subjects.

	Patients	Controls
Sex
Male	55 (0.47)	98 (0.55)
Female	62 (0.53)	78 (0.44)
Age	74.13 ± 12.55	40.06 ± 12.59
Drink
Yes	13 (0.11)
No	104 (0.88)
Smoke
Yes	21 (0.17)
No	96 (0.82)
Coronary heart disease
Yes	70 (0.59)
No	47 (0.40)
Systolic PAP (mmHg)
With CHD	60.60 ± 13.35
Without CHD	60.43 ± 11.57
Left atrial diameter (mm)
With CHD	48.88 ± 9.94
Without CHD	47.37 ± 10.77
LvIDd (mm)
With CHD	52.37 ± 8.65
Without CHD	52.22 ± 11.02
IVST (mm)
With CHD	11.02 ± 5.89
Without CHD	9.95 ± 1.15
LVEF (%)
With CHD	59.01 ± 13.14
Without CHD	56.01 ± 17.85

LvIDd: left ventricular end diastolic diameter; IVST: interventricular septal thickness; LVEF: left ventricular ejection fraction.